BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38254206)

  • 1. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.
    Li J; Zhang B; Feng Z; An D; Zhou Z; Wan C; Hu Y; Sun Y; Wang Y; Liu X; Wei W; Yang X; Meng J; Che M; Sheng Y; Wu B; Wen L; Huang F; Li Y; Yang K
    J Exp Clin Cancer Res; 2024 Jan; 43(1):28. PubMed ID: 38254206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircPITX1 Regulates Proliferation, Angiogenesis, Migration, Invasion, and Cell Cycle of Human Glioblastoma Cells by Targeting miR-584-5p/KPNB1 Axis.
    Cao Y; Wang F; Chen Y; Wang Y; Song H; Long J
    J Mol Neurosci; 2021 Aug; 71(8):1683-1695. PubMed ID: 33763840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.
    Ning F; Du L; Li J; Wu T; Zhou J; Chen Z; Hu X; Zhang Y; Luan X; Xin H; Yuan C; Zhang X
    Life Sci; 2024 Jul; 348():122674. PubMed ID: 38692507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway.
    Yi L; Cui Y; Xu Q; Jiang Y
    Oncol Rep; 2016 Nov; 36(5):2935-2945. PubMed ID: 27632941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination.
    Wang N; Xu J; Wang Y; Zhang X; Zhang H
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):196. PubMed ID: 38625581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance.
    Li Y; Wang T; Wan Q; Wang Q; Chen Z; Gao Y; Ye Y; Lin J; Zhao B; Wang H; Yang J; Zhao K; Lu N
    Cancer Res; 2022 Oct; 82(19):3573-3587. PubMed ID: 35895752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.
    Venkatesh HS; Tam LT; Woo PJ; Lennon J; Nagaraja S; Gillespie SM; Ni J; Duveau DY; Morris PJ; Zhao JJ; Thomas CJ; Monje M
    Nature; 2017 Sep; 549(7673):533-537. PubMed ID: 28959975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deubiquitinase USP7 and E3 ligase TRIM21 regulate vasculogenic mimicry and malignant progression of RMS by balancing SNAI2 homeostasis.
    Zhang R; Zhang D; Han F; Song X; Zhang Y; Zhang J; Zhu Q; Qin Y
    J Exp Clin Cancer Res; 2024 May; 43(1):135. PubMed ID: 38702792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1.
    Lin Y; Zhang J; Li Y; Guo W; Chen L; Chen M; Chen X; Zhang W; Jin X; Jiang M; Xiao H; Wang C; Song C; Fu F
    J Transl Med; 2022 Jan; 20(1):17. PubMed ID: 34991621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.
    Su H; Fan G; Huang J; Qiu X
    Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression.
    Li C; Wang W; Sun Y; Ni Y; Qin F; Li X; Wang T; Guo M; Sun G
    J Exp Clin Cancer Res; 2022 Apr; 41(1):136. PubMed ID: 35410432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiomics analyses reveal
    Zheng C; Wei Y; Zhang Q; Sun M; Wang Y; Hou J; Zhang P; Lv X; Su D; Jiang Y; Gumin J; Sahni N; Hu B; Wang W; Chen X; McGrail DJ; Zhang C; Huang S; Xu H; Chen J; Lang FF; Hu J; Chen Y
    Sci Adv; 2023 Aug; 9(31):eadf3984. PubMed ID: 37540752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion.
    Gupta MK; Polisetty RV; Sharma R; Ganesh RA; Gowda H; Purohit AK; Ankathi P; Prasad K; Mariswamappa K; Lakshmikantha A; Uppin MS; Sundaram C; Gautam P; Sirdeshmukh R
    Sci Rep; 2019 Jul; 9(1):10986. PubMed ID: 31358880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Karyopherin beta 1 suppresses prostate cancer growth.
    Yang J; Guo Y; Lu C; Zhang R; Wang Y; Luo L; Zhang Y; Chu CH; Wang KJ; Obbad S; Yan W; Li X
    Oncogene; 2019 Jun; 38(24):4700-4714. PubMed ID: 30742095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyopherinβ1 regulates proliferation of human glioma cells via Wnt/β-catenin pathway.
    Lu T; Bao Z; Wang Y; Yang L; Lu B; Yan K; Wang S; Wei H; Zhang Z; Cui G
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1189-97. PubMed ID: 27568288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.
    Zhu ZC; Liu JW; Li K; Zheng J; Xiong ZQ
    Oncogene; 2018 May; 37(22):2936-2952. PubMed ID: 29520102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4.
    Pan T; Li X; Li Y; Tao Z; Yao H; Wu Y; Chen G; Zhang K; Zhou Y; Huang Y
    Cancer Cell Int; 2021 Sep; 21(1):508. PubMed ID: 34556124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.